Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Yaozhong Zhao"'
Autor:
Zhongjun Xia, Yun Leng, Baijun Fang, Yang Liang, Wei Li, Chengcheng Fu, Linhua Yang, Xiaoyan Ke, Hua Jiang, Jianyu Weng, Li Liu, Yaozhong Zhao, Xuejun Zhang, Zhongxia Huang, Aichun Liu, Qingzhi Shi, Yuhuan Gao, Xiequn Chen, Ling Pan, Zhen Cai, Zhao Wang, Yafei Wang, Yaqun Fan, Ming Hou, Yigai Ma, Jianda Hu, Jing Liu, Jianfeng Zhou, Xiaohong Zhang, Haitao Meng, Xuzhang Lu, Fei Li, Hanyun Ren, Bintao Huang, Zonghong Shao, Hebing Zhou, Yu Hu, Shifang Yang, Xiangjun Zheng, Peng Wei, Hongyan Pang, Wei Yu, Yuzhang Liu, Sujun Gao, Lingzhi Yan, Yanping Ma, Hongmei Jing, Juan Du, Wei Ling, Jingyi Zhang, Weiwei Sui, Fuxu Wang, Xin Li, Wenming Chen
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Aponermin, a circularly permuted tumor necrosis factor-related apoptosis-inducing ligand, is a potential death receptor 4/5-targeted antitumour candidate. Previous phase 1/2 studies have demonstrated the efficacy of aponermin in p
Externí odkaz:
https://doaj.org/article/b54d9a34e0c7454a9a0589390ee8abee
Autor:
Chenxing Du, Lingna Li, Huishou Fan, Xuehan Mao, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chengwen Li, Jiawei Zhao, Shuhua Yi, Mu Hao, Dehui Zou, Yaozhong Zhao, Lugui Qiu, Gang An
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjective Multiple myeloma is a highly heterogenous plasma cell malignancy, commonly seen in older patients. Age is one of the important prognostic factors. However, nearly all the prognostic staging systems are based on clinical trials, wher
Externí odkaz:
https://doaj.org/article/a0cce3edca314c8c968d083e42e8beb8
Autor:
Zhen Yu, Xiaojing Wei, Lanting Liu, Hao Sun, Teng Fang, Lu Wang, Ying Li, Weiwei Sui, Kefei Wang, Yi He, Yaozhong Zhao, Wenyang Huang, Gang An, Fancui Meng, Changjiang Huang, Tengteng Yu, Kenneth C. Anderson, Tao Cheng, Lugui Qiu, Mu Hao
Publikováno v:
EBioMedicine, Vol 78, Iss , Pp 103950- (2022)
Summary: Background: Multiple myeloma (MM) is still an incurable malignancy of plasma cells. Proteasome inhibitors (PIs) work as the backbone agent and have greatly improved the outcome in majority of newly diagnosed patients with myeloma. However, d
Externí odkaz:
https://doaj.org/article/271b810c490745ecb2266666d34c4ea7
Autor:
Yun Leng, Lugui Qiu, Jian Hou, Yaozhong Zhao, Xuejun Zhang, Shifang Yang, Hao Xi, Zhongxia Huang, Ling Pan, Wenming Chen
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-7 (2016)
Abstract Background Despite the recent development of new therapies, multiple myeloma (MM) remains an incurable disease. Thus, new, effective treatments are urgently needed, particularly for relapsed or refractory MM (RRMM). In an earlier phase I stu
Externí odkaz:
https://doaj.org/article/73182aec26e347c8adcd6b9721567bed
Publikováno v:
IEEE Transactions on Emerging Topics in Computational Intelligence. :1-13
Autor:
Jun Zhu, Jifeng Feng, Chunxia Chen, Weiwei Wang, Qingyuan Zhang, Hongwei Xue, Liling Zhang, Jun Luo, Jianda Hu, Haiwen Huang, Jie Jin, Yaozhong Zhao, Yanyan Liu, Junning Cao, Tongyu Lin, Xinchuan Chen, Jianqiu Wu, Yuqin Song
Purpose:For classical Hodgkin lymphoma (cHL), programmed death-l (PD-1) is a well-recognized attractive target. This multicenter, single-arm, phase II study evaluated the efficacy and safety of camrelizumab, a humanized high-affinity IgG4 mAb against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e7346ea6d2aff4e3067fc943d8e232
https://doi.org/10.1158/1078-0432.c.6528162
https://doi.org/10.1158/1078-0432.c.6528162
Autor:
Lugui Qiu, Kenneth C Anderson, Jianxiang Wang, Kun Ru, Tao Cheng, Junyuan Qi, Yaozhong Zhao, Dehui Zou, Mu Hao, Weiwei Sui, Shuhui Deng, Meirong Zang, Lihui Shi, Jiawei Zhao, Chengwen Li, Xiaoyan Feng, Yan Xu, Shuhua Yi, Xiaoqi Qin, Qian Li, Chirag Acharya, Yu-Tzu Tai, Zengjun Li, Gang An
Purpose: Accumulating evidence indicates that intratumor heterogeneity is prevalent in multiple myeloma and that a collection of multiple, genetically distinct subclones are present within the myeloma cell population. It is not clear whether the size
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467fec9d8f1666977a57e5d03aab65a2
https://doi.org/10.1158/1078-0432.c.6523808.v1
https://doi.org/10.1158/1078-0432.c.6523808.v1
Autor:
Lugui Qiu, Kenneth C Anderson, Jianxiang Wang, Kun Ru, Tao Cheng, Junyuan Qi, Yaozhong Zhao, Dehui Zou, Mu Hao, Weiwei Sui, Shuhui Deng, Meirong Zang, Lihui Shi, Jiawei Zhao, Chengwen Li, Xiaoyan Feng, Yan Xu, Shuhua Yi, Xiaoqi Qin, Qian Li, Chirag Acharya, Yu-Tzu Tai, Zengjun Li, Gang An
Table S1. The distribution of cytogenetics by probes in positive group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726ba6f704304ecf5ffb5350b419c324
https://doi.org/10.1158/1078-0432.22458032
https://doi.org/10.1158/1078-0432.22458032
Autor:
Lugui Qiu, Kenneth C Anderson, Jianxiang Wang, Kun Ru, Tao Cheng, Junyuan Qi, Yaozhong Zhao, Dehui Zou, Mu Hao, Weiwei Sui, Shuhui Deng, Meirong Zang, Lihui Shi, Jiawei Zhao, Chengwen Li, Xiaoyan Feng, Yan Xu, Shuhua Yi, Xiaoqi Qin, Qian Li, Chirag Acharya, Yu-Tzu Tai, Zengjun Li, Gang An
Figure S1. ROC curve for the relation of cytogenetic abnormalities and progression or survival in MM patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1785c2576e7024777295e5eec3ab712f
https://doi.org/10.1158/1078-0432.22458035
https://doi.org/10.1158/1078-0432.22458035
Autor:
Jun Zhu, Jifeng Feng, Chunxia Chen, Weiwei Wang, Qingyuan Zhang, Hongwei Xue, Liling Zhang, Jun Luo, Jianda Hu, Haiwen Huang, Jie Jin, Yaozhong Zhao, Yanyan Liu, Junning Cao, Tongyu Lin, Xinchuan Chen, Jianqiu Wu, Yuqin Song
Efficacy outcome according to investigator's assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73be1ba158bb93d497b31653bc737210
https://doi.org/10.1158/1078-0432.22472229.v1
https://doi.org/10.1158/1078-0432.22472229.v1